Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,680.00
+180.00 (2.77%)
At close: Sep 3, 2026

Finemedix Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-599.38-1,878-24.151,176239.58-1,410
Depreciation & Amortization
932.11961.79995.65964.01959.62983.4
Loss (Gain) From Sale of Assets
--4.87180--1,382-10.53
Loss (Gain) From Sale of Investments
-----6.15
Loss (Gain) on Equity Investments
----240-
Stock-Based Compensation
40.477.88106.3817.73--
Provision & Write-off of Bad Debts
107.02144.9664.928.821.39-11.19
Other Operating Activities
-36.95-551.77174.68160.49559.4891.96
Change in Accounts Receivable
-250.19-175.8-317.04-472.59-840.73709.22
Change in Inventory
638.86-1,114-875.32-128.5-686.44-247.65
Change in Accounts Payable
-17.15-52.38-27.13-34.8430.31-210.88
Change in Unearned Revenue
--0.17--10.120.1410.15
Change in Other Net Operating Assets
105.05-42.06-107.32-302.9-556.31299.1
Operating Cash Flow
919.75-2,634170.681,378-1,435210.19
Operating Cash Flow Growth
---87.61%--2.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-226.04-852.1-595.45-336.13-691.8-1,086
Sale of Property, Plant & Equipment
-7.26--3,77010.45
Cash Acquisitions
-----0.88
Divestitures
----200-
Sale (Purchase) of Intangibles
-1-1---2.76-141.92
Investment in Securities
1,465-4,037780.25577.8-1,404-299.48
Other Investing Activities
-11.5-23.9346.6205.092.66-82.86
Investing Cash Flow
1,226-4,907124.91546.761,774-1,599

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---1,900--
Long-Term Debt Issued
-1,177---1,000
Total Debt Issued
177.211,177-1,900-1,000
Short-Term Debt Repaid
--400--1,000--
Long-Term Debt Repaid
--480.57-542.68-2,115-1,739-1,693
Total Debt Repaid
-486.12-880.57-542.68-3,115-1,739-1,693
Net Debt Issued (Repaid)
-308.91296.64-542.68-1,215-1,739-692.72
Issuance of Common Stock
--9,270---
Other Financing Activities
-30.71-30.71-559.97--8080
Financing Cash Flow
-339.62265.938,167-1,215-1,819-612.72

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
58.260.8865.05-6.11-42.3225.71
Miscellaneous Cash Flow Adjustments
-0----
Net Cash Flow
1,865-7,2748,528703.97-1,522-1,976

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
693.71-3,486-424.771,042-2,127-875.99
Free Cash Flow Growth
------
Free Cash Flow Margin
6.07%-36.61%-4.26%10.26%-26.12%-12.08%
Free Cash Flow Per Share
121.60-641.95-87.93227.36-472.25-269.47
Levered Free Cash Flow
409.93-2,930-938.72406.62-2,159-1,161
Unlevered Free Cash Flow
484.22-2,872-865.84530.88-1,999-1,012

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
54.3387.69126.41102.3960.04183.99
Cash Income Tax Paid
-237.7642.6943.39-0.613.94
Change in Working Capital
476.56-1,384-1,327-948.95-2,053559.95